Crossmark

Medicamentos biosimilares: impacto, oportunidades y estrategias. Doce años de experiencia en Europa

Crossref DOI link: https://doi.org/10.1016/j.medcli.2018.11.013

Published Print: 2019-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Delgado Sánchez, Olga

Ginard Vicens, Daniel

Sampol Mayol, Antonia

Terrasa Pons, Josefa
License Information

Text and Data Mining valid from 2019-05-01
More Information

This article is maintained by: Elsevier

Article Title: Medicamentos biosimilares: impacto, oportunidades y estrategias. Doce años de experiencia en Europa

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2018.11.013

Content Type: article

Copyright: © 2018 Elsevier España, S.L.U. All rights reserved.